Next Article in Journal
A New Tyrosinase Inhibitor from the Red Alga Symphyocladia latiuscula (Harvey) Yamada (Rhodomelaceae)
Previous Article in Journal
A Glycosaminoglycan Extract from Portunus pelagicus Inhibits BACE1, the β Secretase Implicated in Alzheimer’s Disease
Previous Article in Special Issue
Cytotoxic, Anti-Migration, and Anti-Invasion Activities on Breast Cancer Cells of Angucycline Glycosides Isolated from a Marine-Derived Streptomyces sp.
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Three New Isoflavonoid Glycosides from the Mangrove-Derived Actinomycete Micromonospora aurantiaca 110B

1
Ocean College, Zhejiang University, Zhoushan 316021, China
2
College of Biochemical Engineering, Anhui Polytechnic University, Wuhu 241000, China
3
Zhejiang Key Laboratory of Antifungal Drugs, Zhejiang Hisun Pharmaceutical Co., Ltd., Taizhou 318000, China
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2019, 17(5), 294; https://doi.org/10.3390/md17050294
Submission received: 4 May 2019 / Accepted: 13 May 2019 / Published: 17 May 2019
(This article belongs to the Special Issue Natural Products from Marine Actinomycetes)

Abstract

:
The mangrove ecosystem is a rich resource for the discovery of actinomycetes with potential applications in pharmaceutical science. Besides the genus Streptomyces, Micromonospora is also a source of new bioactive agents. We screened Micromonospora from the rhizosphere soil of mangrove plants in Fujian province, China, and 51 strains were obtained. Among them, the extracts of 12 isolates inhibited the growth of human lung carcinoma A549 cells. Strain 110B exhibited better cytotoxic activity, and its bioactive constituents were investigated. Consequently, three new isoflavonoid glycosides, daidzein-4′-(2-deoxy-α-l-fucopyranoside) (1), daidzein-7-(2-deoxy-α-l-fucopyranoside) (2), and daidzein-4′,7-di-(2-deoxy-α-l-fucopyranoside) (3) were isolated from the fermentation broth of strain 110B. The structures of the new compounds were determined by spectroscopic methods, including 1D and 2D nuclear magnetic resonance (NMR) and high-resolution electrospray ionization mass spectrometry (HR-ESIMS). The result of medium-changing experiments implicated that these new compounds were microbial biotransformation products of strain M. aurantiaca 110B. The three compounds displayed moderate cytotoxic activity to the human lung carcinoma cell line A549, hepatocellular liver carcinoma cell line HepG2, and the human colon tumor cell line HCT116, whereas none of them showed antifungal or antibacterial activities.

1. Introduction

The mangrove ecosystem, distinguished by its land-to-ocean transition, is complex and special. Mangroves thrive in a stressful environment of high salinity, high moisture, strong winds, and high osmotic pressure [1]. This environment breeds a distinctive microbial community that can tolerate numerous stresses and has developed unique metabolic pathways for the purpose of structural ecological adaptability [2,3]. Recent research has focused on the diversity of mangrove microorganisms and their metabolic compounds [4,5,6]. Among mangrove microorganisms, actinomycetes have gained more attention due to their ability to produce impressive numbers of bioactive metabolites [3]. There is clear evidence that the mangrove ecosystem contains a large diversity of actinomycetes [7]. As one of the genera of actinomycetes, the genus Micromonospora is an important prolific producer of secondary metabolites [8,9].
The genus Micromonospora, belonging to the family Micromonosporaceae, was proposed by Ørskov [10]. Currently, this genus consists of more than 80 recognized species, according to the List of Prokaryotic Names with Standing in Nomenclature (LPSN) [11]. About 20 new species of Micromonospora have been isolated in the last five years. Many of them were isolated from mangrove environments, such as Micromonospora sediminis CH3-3T [12], Micromonospora ovatispora 2701SIM06T [13], Micromonospora zhanjiangensis 2902at01T [14], Micromonospora sonneratiae 274745T [15], and Micromonospora maritima D10-9-5T [16]. Meanwhile, some new metabolites with biological activities have been isolated from the mangrove-derived Micromonospora strains. Micromonospora rifamycinica AM105 produced rifamycin S and the geometric isomer of rifamycin S with antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA) [17]. Butremycin was isolated from Micromonospora sp. K310 and displayed weak antibacterial activity against Gram-positive Staphylococcus aureus ATCC 25923 and Gram-negative Escherichia coli ATCC 25922 [18]. 3-Methyl-carboline from Micromonospora sp. M2DG17 showed weak inhibitory activity on human colon carcinoma HCT 116 cell lines [19].
In our continuing study of mangrove actinomycetes, 51 strains of Micromonospora were isolated from the rhizosphere soil of mangrove plants in Fujian province. The crude extracts obtained from the isolates were evaluated for cytotoxic activity. Based on the cytotoxic activity, further chemical investigations were performed on Micromonospora aurantiaca 110B. As a result, three new isoflavonoid glycosides (13) were isolated from its fermentation broth. Herein, we describe the isolation, structure elucidation, and cytotoxic activity of these three new compounds.

2. Results

2.1. Isolation and Screening of Strains for Cytotoxic Activities

Fifty-one strains belonging to the genus Micromonospora were isolated from mangrove soil samples. The crude extracts of these isolates were examined for their cytotoxic activity. After primary screening, 12 strains showed cytotoxic activity to the human lung tumor cell line A549 (Figure 1). The 16S rRNA genes of the 12 strains were sequenced and the sequences were blasted against GenBank (https://www.ncbi.nlm.nih.gov/genbank/). The results showed that the isolates belonged to seven different species (Figure 2) and that strain 110B was closely related to the type strain Micromonospora aurantiaca ATCC 27029T (CP002162).
Due to the superior cytotoxic activity of strain 110B, further chemical investigations were performed on this strain.

2.2. Structural Elucidation

The strain 110B was grown in a preparative scale in 30 L of fermentation medium for 7 days. A chemical investigation of its fermentation broth led to the isolation of three new isoflavonoid glycosides (compounds 13).
Compound 1 was obtained as a white powder with a negative specific rotation value ([α ] D 25 −107, EtOH) and UV (EtOH) λmax (log ε) 249 (4.49), 301 (4.10) nm. The molecular formula of 1 was established to be C21H20O7 from positive-ion HR-ESIMS (Figure S1) and 13C NMR spectral (Figure S4) data (Table 1). The IR spectrum (Figure S2) of 1 revealed carbonyl group absorption at 1628 cm−1 and hydroxy group absorption at 3353 cm−1. The 1H NMR (Figure S3) data (Table 1) showed the characteristic isoflavone signal for H-2 at δH 8.08 (1H, s); two sets of aromatic hydrogen peaks at δH 7.39 (2H, d, J = 8.7 Hz) and δH 7.05 (2H, d, J = 8.7 Hz) corresponding to a 4-hydroxyphenyl moiety (B ring); three aromatic protons corresponding to a 7-substituted A ring at δH 7.97 (1H, d, J = 9.0 Hz), 6.84 (1H, dd, J = 9.0, 2.4 Hz), and δH 6.76 (1H, d, J = 2.4 Hz); and nine proton signals attributable to sugars at δH 5.62 (1H, br d, J = 3.5 Hz), 4.09 (1H, ddd, J = 11.9, 5.0, 3.0 Hz), 3.89 (1H, q, J = 6.6 Hz), 3.55 (1H, br d, J = 3.0 Hz), 2.03 (1H, ddd, J = 12.8, 11.9, 3.6 Hz), 1.90 (1H, dd J = 12.8, 5.0 Hz), and δH 1.10 (3H, d, J = 6.6 Hz). The 13C NMR spectrum (Table 1) displayed 21 carbon resonances, including 15 carbons for the isoflavone skeleton and 6 carbons for the sugar. The NMR spectral (Figure S6) data suggested that compound 1 was an isoflavone glycoside, and the isoflavone skeleton proved to be daidzein based on a comparison of the spectroscopic data with previously reported values [20,21]. The 6-carbon resonances of sugar can be categorized as 1 methyl (δC 18.4), 1 methylene (δC 32.09), 1 acetal (δC 97.6), and 3 methines (δC 72.1, 68.6, 66.7) by 13C NMR and distortionless enhancement by polarization transfer (DEPT, Figure S5) experiments, indicating the presence of a 2,6-dideoxysugar moiety. The correlations of H-1″/H2-2″/H-3″/H-4″/H-5″/H3-6″ in the 1H–1H correlation spectroscopy (COSY) spectrum (Figure 3 and Figure S7) and the observed heteronuclear multiple bond correlation (HMBC) signals (Figure 3 and Figure S8) from H-1″ to C-5″ and H3-6″ to C-4″ further established the 2,6-dideoxysugar structure. In the HMBC experiment, the correlation between the anomeric proton (H-1″) and the carbon at δC 158.3 (C-4′) confirmed the attachment of the sugar moiety to the phenolic 4′-O-atom. From the detailed analysis of the 1H NMR spectrum, the small coupling constant of H-1″ (δH 5.62 br d, J = 3.5 Hz) revealed that the sugar is α-glycosidically linked to the phenolic oxygen atom [22]. The signal patterns of H-3″ (δH 4.09 ddd, J = 11.9, 5.0, 3.0 Hz) and H-4″ (δH 3.55 br d, J = 3.0 Hz) showed equatorial 3″-OH and axial 4″-OH groups. Further, signals at H-4″ exhibited 3.0 coupling, which could be assigned to the axial H-5″ and axial H-3″, respectively. This 2,6-dideoxysugar was assumed to be 2-deoxy-l-fucose on the basis of 1H and 13C NMR data [23,24] and the NOESY experiment (Figure S9). Acid hydrolysis of compound 1 afforded the aglycone daidzein and a 2-deoxy-l-fucose. The aglycone fraction was identified by HPLC analysis. The retention time of the aglycone moiety of 1 was in good agreement with that of daidzein (Figure S28). The sugar fraction liberated by acid hydrolysis was treated with l-cysteine methyl ester, followed by reaction with O-tolylisothiocyanate. By reversed-phase HPLC analysis, the identical retention time of the liberated sugar derivative with that of the 2-deoxy-l-fucose derivative indicated that the sugar moiety of 1 was 2-deoxy-fucose (Figure S29). Consequently, the structure of 1 was elucidated to be daidzein-4′-(2-deoxy-α-l-fucopyranoside) (Figure 3 and Figure 4).
Compound 2 was obtained as a white powder with a negative specific rotation value ([α ] D 25 −112, EtOH). The molecular formula of 2 was established as C21H20O7 from positive-ion HR-ESIMS (Figure S10) and 13C NMR spectral data (Table 1). Bands for hydroxy group at 3357 cm−1 and the carbonyl group at 1634 cm−1 were evident in the IR spectrum (Figure S11). In the 1H NMR spectrum (Table 1) of 2, the characteristic H-2 signal of an isoflavone was exhibited at δH 8.12 (1H, s), and the 4-hydroxyphenyl nature of the B ring was deduced from the signals at δH 7.31 (2H, d, J = 9.0 Hz) and δH 6.78 (2H, d, J = 9.0 Hz). Three aromatic proton signals were observed at δH 8.06 (1H, d, J = 9.0 Hz), 7.18 d (1H, d, J = 2.3 Hz), and δH 7.09 (1H, dd, J = 9.0, 2.3 Hz), indicating that the A ring was substituted at C-7. An anomeric proton signal at δH 5.78 d (1H, br d, J = 3.6 Hz) also appeared in the 1H NMR spectrum of 2. Comparison of the NMR data (Figures S12–S18) of 2 with those of 1 revealed close similarities, except for the substituted pattern of the 2,6-dideoxysugar moiety. The observed HMBC correlation (Figure 3) from the anomeric proton H-1″ to C-7 (δC 163.1) confirmed the position of the 2,6-dideoxysugar. The 2,6-dideoxysugar was deduced to be 2-deoxy-l-fucose according to HPLC analysis of the corresponding O-tolylthiocarbamate derivative of the liberated sugar, as described above. Thus, the structure of 2 was identified as daidzein-7-(2-deoxy-α-l-fucopyranoside) (Figure 3).
Compound 3 was obtained as a white powder with a negative specific rotation value ([α ] D 25 −27.0, EtOH). The molecular formula of 3 was deduced to be C27H30O10 from positive-ion HR-ESIMS (Figure S19) and 13C NMR spectral data (Table 1). The IR spectrum (Figure S20) revealed carbonyl absorption at 1650 cm−1 and hydroxy absorption at 3381 cm−1. The 1H NMR spectrum of 3 (Table 1) showed eight aromatic proton signals at δH 8.21 (1H, s), 8.12 (1H, d, J = 8.9 Hz), 7.47 (2H, d, J = 8.7 Hz), 7.25 (2H, d, J = 2.2 Hz), 7.15 (1H, dd, J = 8.9, 2.2 Hz), and δH 7.13 (1H, d, J = 8.7 Hz), indicating that the isoflavone aglycone of 3 was identical to 1 and 2. Two sugar moieties were evident from the anomeric proton signals at δH 5.84 (1H, br d, J = 3.5 Hz) and δH 5.69 (1H, br d, J = 3.5 Hz) in the 1H NMR spectrum. The 1H and 13C NMR spectral (Figures S21–S23) data of 3 were similar to those of 1 and 2, except for an extra 2,6-dideoxysugar moiety. The HMBC (Figure S26) correlations from H-1″ to C-4′ and H-1‴ to C-7 revealed that the two 2,6-dideoxysugar moieties were located at C-4′ and C-7, respectively. The sugar moieties of 3 were determined by HPLC analysis of the O-tolylthiocarbamate derivative of the liberated sugar from acid hydrolysis and a standard 2-deoxy-l-fucose derivative. So, the structure of 3 was determined to be daidzein-4′,7-di-(2-deoxy-α-l-fucopyranoside), as shown in Figure 3.
Isoflavonoids have been frequently isolated from bacterial and fungal cultures, but their biosynthetic origin has not been unveiled in all cases. Not all of the isoflavonoids were synthesized ‘de novo’. Ndejouong and Hertweck found that Streptomyces mirabilis could transform isoflavones into hydroxylated and reduced derivatives [25]. In order to clarify whether compounds 13 were synthesized ‘de novo’, we carried out a series of experiments. We prepared different media (media 1–4) to explore whether the ingredients in the fermentation medium will affect the production of compounds 13, and we mainly focused on the medium that lacked soybean cake or peptone. We found that the three new compounds were only detected in medium containing soybean cake. Then, when daidzein was added to the medium lacking soybean cake (giving medium 5), we could observe formation of these new compounds (Figure 5). These results indicated that M. aurantiaca 110B could transform plant daidzein into fucosylated derivatives.

2.3. Analysis of Deoxy-Sugar Glycosyltransferases

The genome of the strain 110B was sequenced and analyzed. We focused on whether there were any deoxy-sugar-related enzymes in strain M. aurantiaca 110B because the sugar moieties of the three new isoflavonoid glycosides were 2,6-dideoxysugars. Deoxy-sugar glycosyltransferases are interesting enzymes because of their important role in many natural product drugs. Glycosyltransferase-related protein sequences of the M. aurantiaca 110B were aligned with protein sequences of the UniProt database [26,27], and one protein (AXH94677.1) similar to AknK was found (Figure 6). AknK is an l-2-deoxy-l-fucose transferase found in Streptomyces galilaeus, which catalyzes the addition of the second sugar to aclacinomycin A [28]. The genome information of strain 110B also showed that the sugar moieties of the three new isoflavonoid glycosides might be 2-deoxy-fucose. This conclusion was consistent with the results of the structural analysis.

2.4. Biological Activity

Compounds 13 were tested for their activity against the proliferation of the human hepatocellular liver carcinoma cell line HepG2, human lung tumor cell line A549, and human colon tumor cell line HCT116. The results (Table 2) showed that the three compounds exhibited moderate cytotoxic activity against the three cell lines.
The antifungal and antibacterial properties of the three compounds were tested against three human pathogens: the fungus Candida albicans, the Gram-positive bacterium methicillin-resistant S. aureus, and the Gram-negative bacterium E. coli. The minimum inhibitory concentrations (MICs) of compounds 13 were determined to be >10 mg/mL, so the new compounds had no activity against these tested pathogens.

3. Materials and Methods

3.1. General Experimental Procedures

Optical rotation was measured on a Perkin-Elmer 341 polarimeter (Perkin-Elmer, Suzhou, China). IR spectra were recorded on a Nicolet Magna FT-IR 750 spectrometer (Nicolet, Tokyo, Japan). UV spectra were recorded on a Varian CARY 300 BIO spectrophotometer (Varian, Cary, NC, USA). The HR-ESIMS spectra were taken on a Q-TOF Micro LC-MS-MS mass spectrometer (Waters Co, Milford, MA, USA). NMR spectra were measured with a Bruker DRX-400 (400 MHz for 1H and 100 MHz for 13C) spectrometer (Bruker, Rheinstetten, Germany). HPLC separation was performed on semipreparative HPLC (Agilent 1100, Zorbax SB-C18, 5 μm, 250 × 9.4 mm inner diameter; 1.5 mL/min; 220 nm; Agilent, Palo Alto, CA, USA). Column chromatography was performed with commercial silica gel (Qing Dao Hai Yang Chemical Group Co., 100–200 and 200–300 mesh). Silica gel plates HSGF254 (Yantai Chemical Industry Research Institute, Yantai, China) were used for thin-layer chromatography (TLC).

3.2. Isolation and Identification of Strain

Mangrove soils were collected from Zhangzhou (24°20′, 117°45′), Fujian province, China. The samples were placed into clean plastic bags and stored at 4 °C prior to isolation. Samples were dried and mixed with sterile deionized water, and actinobacteria were isolated by plating the resulting suspensions on four different selective isolation media: M6 (raffinose–histidine medium), M8 (glycerol asparagine agar medium), HV (humic acid–vitamin agar), and GP (glucose–tryptone agar medium). All of the media were supplemented with 25 mg/L of nalidixic acid and 50 mg/L of nystatin. Also, 10% supernatant of the strain Micrococcus luteus JCM 21373T, which contained resuscitation-promoting factor (rpf), was added to each medium. The strain M. luteus JCM 21373T was inoculated in LMM (lactate minimal medium) at a rate of 5% (v/v) and incubated at 30 °C for 48 h until the end of the logarithmic growth phase [29]. Then, the culture supernatant was collected following centrifugation at 10,000 rpm and sterilized by filtration through a 0.22-μm filter. After incubation, isolates with Micromonospora-like morphology were transferred to ISP medium 2 (yeast extract-malt extract agar) and incubated for 7–10 days at 28 °C.
All isolates were grown in marine broth 2216 (MB, difco) medium for 5 days at 30 °C. Genomic DNA was extracted using the Bacteria Genomic DNA Extraction Kit (DongSheng Biotech) according to the manufacturer’s instructions. For phylogenetic studies, the 16S rRNA gene was amplified using two universal primers: 27F (5’-GAGTTTGATCCTGGCTCAG-3’) and 1492R (5’-AGAAAGGAGGTGATCCAGCC-3’) [30]. Amplification reactions were prepared in a 25-μL final reaction volume containing 11 μL of distilled water, 12.5 μL of PCR SuperMix, 1 μL of each primer (2.5 μM), and 0.5 μL of extracted DNA (template). PCR was performed under the following conditions: 30 cycles of 94 °C/5 min, 4 °C/30 s, 55 °C/30 s, 72 °C/75 s, and a final extension of 72 °C/10 min. PCR products were detected by agarose gel electrophoresis. The obtained sequence of each strain was assembled with DNASTAR SeqMan (LaserGene, Madison, WI). The 16S rRNA gene sequence was analyzed using the ExTaxon-e service [31] and the BLASTN program (https://blast.ncbi.nlm.nih.gov/Blast.cgi). For phylogenetic analysis, multiple sequence alignment was accomplished via the CLUSTAL W program of the MEGA 5 package [32]. The strain 110B was identified as M. aurantiaca because its 16S rRNA sequence (accession no: MH333275 in the GenBank) exhibited a high sequence similarity of 100% with that of M. aurantiaca ATCC 27029T (accession no: CP002162).

3.3. Preparation of Crude Extracts

All strains were inoculated into 250-mL Erlenmeyer flasks containing 30 mL of MB medium and incubated at 28 °C for 7 days while shaking at 200 rpm. After cultivation, 60 mL of methanol was added to each of the cultures. After 24 h, the mixture was filtered and concentrated under vacuum. The extracts were dissolved in dimethyl sulfoxide for cytotoxic evaluation.

3.4. Fermentation and Extraction of Strain 110B

Strain 110B was inoculated into a 1000-mL flask containing 250 mL of seed culture medium consisting of (in %) malt extract (1.0), glucose (0.4), yeast extract (0.4), and CaCO3 (0.2), with a pH of 7.2–7.4. Incubation was carried out at 28 °C for 3 days on a rotary shaker operating at 250 rpm. Then, a 5.0% seed culture broth was cultured in a 50-L fermenter (containing 30 L of fermentation medium) at 28 °C for 7 days. The fermentation medium was a modified 2216 medium which contained (per liter distilled water): soybean cake (20 g), maltodextrin (10 g), peptone (5.0 g), yeast extract (10 g), glucose (10 g), NaCl (19.45 g), MgCl2·6H2O (12.6 g), MgSO4·7H2O (6.64 g), CaCl2 (1.8 g), KCl (0.55 g), NaHCO3 (0.16 g), H3BO3 (22.0 mg), KBr (0.08 g), Na2SiO3 (4.0 mg), NaF (2.4 mg), NH4NO3 (1.6 mg), Na2PO4 (8.0 mg), SrCl2·6H2O (57 mg), and ferric citrate (0.1 g).
The final 30 L of fermentation broth was centrifuged to separate the mycelial cake and supernatant. The mycelial cake was washed with water (3 L) and subsequently extracted with MeOH (3 L). The supernatant and the wash water were passed through a Diaion HP-20 resin column (Mitsubushi Chemical Co, Ltd., Tokyo, Japan) and eluted with 95% EtOH. The MeOH extract and the EtOH eluents were evaporated under reduced pressure to yield a mixture (25 g) at 50 °C. The mixture was chromatographed on a silica gel column (Qingdao Haiyang Chemical Group, Qingdao, China; 100–200 mesh) and successively eluted with CHCl3/MeOH (100:0, 98:2, 95:5, 90:10, 85:15, 80:20, 70:30, 60:40, and 50:50 v/v) to give six fractions (Fr.1–6) based on the TLC profiles. After the Fr.3 was concentrated in vacuo, the material was subjected to a Sephadex LH-20 gel column (GE Healthcare, Glies, UK), eluted with CHCl3/MeOH (1:1, v/v), and detected using TLC to give three fractions (Fr.3-1–3-3). Fr.3-2 was further analyzed and purified by semipreparative reversed-phase HPLC eluting with CH3CN/H2O (30:70, v/v) to give compounds 1 (tR 15.5 min, 12.2 mg) and 2 (tR 13.5 min, 10.1 mg). Fr.4 was subjected to a Sephadex LH-20 column eluted with CHCl3/MeOH (1:1, v/v) and detected by TLC to give three subfractions (Fr.4-1–4-3). Fr.4-2 was further separated by semipreparative reversed-phase HPLC eluting with CH3CN/H2O (30:70, v/v) to give compound 3 (tR 10.6 min, 8.9 mg).
Compound 1: white powder; [α ] D 25 −107 (c 0.04, EtOH); IR (KBr) νmax 3663, 3553, 2984, 2905, 1628, 1407, 1049 cm−1; UV (EtOH) λmax (log ε) 249 (4.49), 301 (4.10) nm; 1H (400 MHz) and 13C NMR (100 MHz) data, see Table 2; positive HR-ESIMS m/z 385.1286 [M + H]+ (calcd. for C21H21O7, 385.1282).
Compound 2: white powder; [α ] D 25 −112 (c 0.04, EtOH); IR (KBr) νmax 3357, 2984, 2838, 1634, 1408, 1023 cm−1; UV (MeOH) λmax (log ε) 249 (4.18), 262 (4.23), 305 (3.76) nm; 1H (400 MHz) and 13C NMR (100 MHz) data, see Table 2; positive HR-ESIMS m/z 385.1287 [M + H]+ (calcd. for C21H21O7, 385.1282).
Compound 3: white powder; [α ] D 25 −27 (c 0.04, EtOH); IR (KBr) νmax 3381, 2987, 1650, 1450, 1407, 1022 cm−1; UV (MeOH) λmax (log ε) 249 (4.16), 259 (4.23), 305(3.81) nm; 1H (400 MHz) and 13C NMR (100 MHz) data, see Table 2; positive HR-ESIMS m/z 515.1912 [M + H]+ (calcd. for C27H31O10, 515.1912).

3.5. Determination of Aglycone Moieties and Sugars Configuration

Compounds 1 (2.0 mg), 2 (2.0 mg), and 3 (1.5 mg) were refluxed with 2 mL of 2 N HCl and heated for 2 h at 80 °C. After being neutralized with NaHCO3, the hydrolysate was extracted with EtOAc to separate the organic and aqueous layers. The organic layer was dried in vacuo and subjected to column chromatography using a Zorbax B-C18 column, mobile phase of CH3CN/H2O (30:70, v/v), flow rate of 1.5 mL/min−1, and detection wavelength at 254 nm. HPLC analysis of the aglycone-containing fractions of 13 gave peaks at 22.34, 22.38, and 22.46 min, respectively, while the tR values for standard daidzein were observed at 22.47 min, suggesting that the aglycone moieties of 13 were daidzein. The aqueous fraction was evaporated in vacuo and the sugar residue was dissolved in pyridine (2 mL) containing l-cysteine methyl ester hydrochloride (1.0 mg), followed by heating at 60 °C for 1 h. A 25-μL solution of O-tolylisothiocyanate was added to the mixture, which was heated at 60 °C for a further 1 h [33]. Likewise, the O-tolylthiocarbamate derivative of 2-deoxy-l-fucose was prepared according to the method described above. Then, the O-tolylthiocarbamate derivatives were analyzed by reversed-phase HPLC (Amethyst C18-H, 5 μm, 250 × 4.6 mm inner diameter; 0.8 mL/min−1; 250 nm) eluting with CH3CN/H2O (30:70, v/v). Under these conditions, the derivative of standard sugar gave a peak at tR (min) = 25.06, while O-tolylthiocarbamate derivatives of the liberated sugars of 13 showed peaks at 25.40, 25.02, and 25.02 min, respectively. The sugar moieties of the three new compounds (13) were identified as 2-deoxy-l-fucose.

3.6. Biological Assays

The antimicrobial activity of the three compounds against pathogenic fungi C. albicans, pathogenic bacteria methicillin-resistant S. aureus, and E. coli was investigated with the minimum inhibitory concentration (MIC) method recommended by the Clinical and Laboratory Standards Institute [34]. Gentamicin (an antibacterial antibiotic) and amphotericin B (an antifungal antibiotic) were used as a positive control.
The cytotoxicity of the three compounds was assayed in vitro against the human lung carcinoma cell line A549, hepatocellular liver carcinoma cell line HepG2, and the human colon tumor cell line HCT116 by the cell counting kit-8 (CCK8) colorimetric method. The cell lines were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% calf serum at 37 °C for 4 h in a 5% CO2 incubator. The adherent cells of the logarithmic growth stage were digested and seeded in a 96-well culture plate at a density of 1 × 104 cells per/well. Test samples and control were added to the medium and incubated for 48 h. Then, the cell counting kit-8 (CCK-8, Dojindo, Kumamoto, Japan) reagent was added to the medium and incubated for 3 h. Cell viability was measured by absorbance at 450 nm using a SpectraMax M5 microplate reader (Molecular Devices Inc., Sunnyvale, CA, USA) [35]. The inhibitory rate of cell proliferation was expressed as IC50 values. Doxorubicin was used as a positive control, and cell solutions containing 0.5% DMSO were tested as a negative control.

4. Conclusions

The study was designed to isolate mangrove-derived Micromonospora strains and explore their bioactive metabolites. Fifty-one strains belonging to the genus Micromonospora were isolated, and the crude extracts of 12 isolates showed cytotoxic activity against the human lung carcinoma cell line A549. Furthermore, a chemical investigation was carried out on the strain M. aurantiaca 110B. This investigation led to the isolation of three new isoflavonoid glycosides (compounds 13). The structures of the new compounds were determined by NMR, HR-ESIMS, acid hydrolysis, and HPLC analysis on the O-tolylthiocarbamate derivatives of sugar moieties. Moreover, the three new compounds were the result of biotransformation by the strain M. aurantiaca 110B. The three compounds showed moderate activity against the human lung carcinoma cell line A549, hepatocellular liver carcinoma cell line HepG2, and the human colon tumor cell line HCT116.

Supplementary Materials

The following are available online https://www.mdpi.com/1660-3397/17/5/294/s1: HR-ESIMS and NMR spectra (Figures S1–S29) of compounds 13, as well as other supporting data.

Author Contributions

R.-J.W. isolated strain 110B, new compounds, and prepared the manuscript. Y.-H.Y. and H.Q. tested the biological activities. S.-Y.Z. performed the spectroscopic data analysis. Z.Y. undertook the genome analysis. H.Z. and Z.-L.X. designed the experiments. J.-D.W. and M.W. determined the final structures of new compounds and guided the manuscript writing.

Funding

This work was supported by the China Ocean Mineral Resources R&D Association (grant No. DY135-E2-2-05).

Acknowledgments

The authors thank Yu Liu (Life Science Institute of Zhejiang University) for performing NMR spectrometry.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kathiresan, K.; Bingham, B.L. Biology of mangroves and mangrove ecosystems. Adv. Mar. Biol. 2001, 40, 81–251. [Google Scholar] [CrossRef]
  2. Jiang, X.T.; Peng, X.; Deng, G.H.; Sheng, H.F.; Wang, Y.; Zhou, H.W.; Tam, N.F.Y. Illumina sequencing of 16S rRNA tag revealed spatial variations of bacterial communities in a mangrove wetland. Microb. Ecol. 2013, 66, 96–104. [Google Scholar] [CrossRef]
  3. Xu, J. Biomolecules produced by mangrove-associated microbes. Curr. Med. Chem. 2011, 18, 5224–5266. [Google Scholar] [CrossRef]
  4. Gomes, N.C.M.; Borges, L.R.; Rodolfo, P.; Pinto, F.N.; Mendonça-Hagler, L.C.S.; Smalla, K. Exploring the diversity of bacterial communities in sediments of urban mangrove forests. FEMS Microbiol. Ecol. 2010, 66, 96–109. [Google Scholar] [CrossRef] [PubMed]
  5. Thatoi, H.; Behera, B.C.; Mishra, R.R.; Dutta, S.K. Biodiversity and biotechnological potential of microorganisms from mangrove ecosystems: a review. Ann. Microbiol. 2013, 63, 1–19. [Google Scholar] [CrossRef]
  6. Ghizelini, A.M.; Mendonça-Hagler, L.C.S.; Macrae, A. Microbial diversity in Brazilian mangrove sediments―A mini review. Braz. J. Microbiol. 2012, 43, 1242–1254. [Google Scholar] [CrossRef]
  7. Hong, K.; Gao, A.H.; Xie, Q.Y.; Gao, H.; Zhuang, L.; Lin, H.P.; Yu, H.P.; Li, J.; Yao, X.S.; Goodfellow, M.; et al. Actinomycetes for marine drug discovery isolated from mangrove soils and plants in China. Mar. Drugs 2009, 7, 24–44. [Google Scholar] [CrossRef]
  8. Abdelmohsen, U.R.; Bayer, K.; Hentschel, U. Diversity, abundance and natural products of marine sponge-associated actinomycetes. Nat. Prod. Rep. 2014, 31, 381–399. [Google Scholar] [CrossRef] [PubMed]
  9. Velhopereira, S.; Kamat, N.M. Antimicrobial screening of actinobacteria using a modified cross-streak method. Indian. J. Pharm. Sci. 2012, 73, 223–228. [Google Scholar] [CrossRef]
  10. Hirsch, A.M.; Valdés, M. Micromonospora: An important microbe for biomedicine and potentially for biocontrol and biofuels. Soil. Biol. Biochem. 2010, 42, 536–542. [Google Scholar] [CrossRef]
  11. Euzéby, J.P. List of bacterial names with standing in nomenclature: A folder available on the internet. Int. J. Syst. Evol. Microbiol. 1997, 47, 590–592. [Google Scholar] [CrossRef]
  12. Phongsopitanun, W.; Kudo, T.; Ohkuma, M.; Pittayakhajonwut, P.; Suwanborirux, K.; Tanasupawat, S. Micromonospora sediminis sp. nov., isolated from mangrove sediment. Int. J. Syst. Evol. Microbiol. 2016, 66, 3235–3240. [Google Scholar] [CrossRef] [PubMed]
  13. Li, L.; Hong, K. Micromonospora ovatispora sp. nov. isolated from mangrove soil. Int. J. Syst. Evol. Microbiol. 2016, 66, 889–893. [Google Scholar] [CrossRef]
  14. Zhang, L.; Li, L.; Deng, Z.; Hong, K. Micromonospora zhanjiangensis sp. nov., isolated from mangrove forest soil. Int. J. Syst. Evol. Microbiol. 2015, 65, 4880–4885. [Google Scholar] [CrossRef]
  15. Li, L.; Tang, Y.L.; Wei, B.; Xie, Q.Y.; Deng, Z.; Hong, K. Micromonospora sonneratiae sp. nov., isolated from a root of Sonneratia apetala. Int. J. Syst. Evol. Microbiol. 2013, 63, 2383–2388. [Google Scholar] [CrossRef] [PubMed]
  16. Songsumanus, A.; Tanasupawat, S.; Igarashi, Y.; Kudo, T. Micromonospora maritima sp. nov., isolated from mangrove soil. Int. J. Syst. Evol. Microbiol. 2013, 63, 554–559. [Google Scholar] [CrossRef] [PubMed]
  17. Azman, A.S.; Othman, I.; Velu, S.S.; Chan, K.G.; Lee, L.H. Mangrove rare actinobacteria: taxonomy, natural compound, and discovery of bioactivity. Front. Microbiol. 2015, 6, 856. [Google Scholar] [CrossRef]
  18. Kyeremeh, K.; Acquah, K.S.; Sazak, A.; Houssen, W.; Tabudravu, J.; Deng, H.; Jaspars, M. Butremycin, the 3-hydroxyl derivative of ikarugamycin and a protonated aromatic tautomer of 5’-methylthioinosine from a ghanaian Micromonospora sp. K310. Mar. Drugs 2014, 12, 999–1012. [Google Scholar] [CrossRef]
  19. Xu, D.B.; Ye, W.W.; Han, Y.; Deng, Z.X.; Hong, K. Natural products from mangrove actinomycetes. Mar. Drugs 2014, 12, 2590–2613. [Google Scholar] [CrossRef]
  20. Al-Maharik, N.; Botting, N.P. An efficient method for the glycosylation of isoflavones. Eur. J. Org. Chem. 2008, 33, 5622–5629. [Google Scholar] [CrossRef]
  21. Kang, H.R.; Lee, D.; Benndorf, R.; Jung, W.H.; Beemelmanns, C.; Kang, K.S.; Kim, K.H. Termisoflavones A-C, isoflavonoid glycosides from termite-associated Streptomyces sp. RB1. J. Nat. Prod. 2016, 79, 3072–3078. [Google Scholar] [CrossRef] [PubMed]
  22. Fischer, C.; Rodriguez, L.; Patallo, E.P.; Lipata, F.; Braña, A.F.; Méndez, C.; Salas, J.A.; Rohr, J. Digitoxosyltetracenomycin C and glucosyltetracenomycin C, two novel elloramycin analogues obtained by exploring the sugar donor substrate specificity of glycosyltransferase ElmGT. J. Nat. Prod. 2002, 65, 1685–1689. [Google Scholar] [CrossRef] [PubMed]
  23. Parkinson, J.A.; Sadler, I.H.; Pickup, M.B.; Tabor, A.B. Complete assignment of the 1H and 13C NMR spectra and solution conformation of the antitumour antibiotic, aclacinomycin A. Tetrahedron 1995, 51, 7215–7222. [Google Scholar] [CrossRef]
  24. Gui, C.; Yuan, J.; Mo, X.H.; Huang, H.B.; Zhang, S.W.; Gu, Y.C.; Ju, J.H. Cytotoxic anthracycline metabolites from a recombinant Streptomyces. J. Nat. Prod. 2018, 81, 1278–1289. [Google Scholar] [CrossRef] [PubMed]
  25. Ndejouong, B.L.S.T.; Sattler, I.; Dahse, H.M.; Kothe, E.; Hertweck, C. Isoflavones with unusually modified B-rings and their evaluation as antiproliferative agents. Cheminform 2009, 43, 4548–4558. [Google Scholar] [CrossRef]
  26. Bairoch, A.; Apweiler, R.; Wu, C.H.; Barker, W.C.; Boeckmann, B.; Ferro, S.; Gasteiger, E.; Huang, H.Z.; Lopez, R.; Magrane, M.; et al. The universal protein resource (UniProt). Nucleic. Acids. Res. 2005, 33, 154–159. [Google Scholar] [CrossRef]
  27. Consortium, U.P. UniProt: A hub for protein information. Nucleic. Acids. Res. 2015, 43, 204–212. [Google Scholar] [CrossRef]
  28. Lu, W.; Leimkuhler, C.; Oberthür, M.; Kahne, D.; Walsh, C.T. AknK is an l-2-deoxyfucosyltransferase in the biosynthesis of the anthracycline aclacinomycin A. Biochemistry 2004, 43, 4548–4558. [Google Scholar] [CrossRef]
  29. Yu, X.Y.; Zhang, L.; Ren, B.; Yang, N.; Liu, M.; Liu, X.T.; Zhang, L.X.; Ding, L.X. Arthrobacter liuii sp. nov., resuscitated from Xinjiang desert soil. Int. J. Syst. Evol. Microbiol. 2015, 65, 896–901. [Google Scholar] [CrossRef]
  30. Embley, T. The linear PCR reaction: A simple and robust method for sequencing amplified rRNA genes. Lett. Appl. Microbiol. 1991, 13, 171–174. [Google Scholar] [CrossRef] [PubMed]
  31. Kim, O.S.; Cho, Y.J.; Lee, K.; Yoon, S.H.; Kim, M.; Na, H.; Park, S.C.; Jeon, Y.S.; Lee, J.H.; Yi, H.; et al. Introducing EzTaxon-e: A prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int. J. Syst. Evol. Microbiol. 2012, 62, 716–721. [Google Scholar] [CrossRef] [PubMed]
  32. Tamura, K.; Peterson, D.; Peterson, N.; Stecher, G.; Nei, M.; Kumar, S. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28, 2731–2739. [Google Scholar] [CrossRef] [PubMed]
  33. Chao, C.H.; Chou, K.J.; Huang, C.Y.; Wen, Z.H.; Hsu, C.H.; Wu, Y.C.; Dai, C.F.; Sheu, J.H. Steroids from the soft coral Sinularia crassa. Mar. Drugs 2012, 10, 439–450. [Google Scholar] [CrossRef] [PubMed]
  34. Jorgensen, J.H.; Hindler, J.F.; Reller, L.B.; Weinstein, M.P. New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin. Infect. Dis. 2007, 44, 280–286. [Google Scholar] [CrossRef] [PubMed]
  35. Wang, J.D.; Zhang, H.; Ying, L.P.; Wang, C.X.; Jiang, N.; Zhou, Y.; Wang, H.B.; Bai, H. Five new epothilone metabolites from Sorangium cellulosum strain So0157-2. J. Antibiot. 2009, 62, 483–487. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Cytotoxic activity of extracts obtained from 12 isolates against the human lung tumor cell line A549 in vitro.
Figure 1. Cytotoxic activity of extracts obtained from 12 isolates against the human lung tumor cell line A549 in vitro.
Marinedrugs 17 00294 g001
Figure 2. Neighbor-joining phylogenetic tree based on nearly complete 16S rRNA gene sequences showing relationships between the 12 active isolates and the type strains of the highest 16S rDNA sequence similarity. Bootstrap values were based on 1000 replicates; only values ≥50% are shown. Bar: 0.002 substitutions per nucleotide position.
Figure 2. Neighbor-joining phylogenetic tree based on nearly complete 16S rRNA gene sequences showing relationships between the 12 active isolates and the type strains of the highest 16S rDNA sequence similarity. Bootstrap values were based on 1000 replicates; only values ≥50% are shown. Bar: 0.002 substitutions per nucleotide position.
Marinedrugs 17 00294 g002
Figure 3. The structures and key 1H–1H COSY and HMBC correlations for compounds 13.
Figure 3. The structures and key 1H–1H COSY and HMBC correlations for compounds 13.
Marinedrugs 17 00294 g003
Figure 4. The key NOESY correlations for compound 1.
Figure 4. The key NOESY correlations for compound 1.
Marinedrugs 17 00294 g004
Figure 5. HPLC analysis of the formation of compounds 13 in different media, with a mobile phase of CH3CN/H2O (25:75, v/v), flow rate of 1.5 mL/min−1, and detection wavelength at 254 nm.
Figure 5. HPLC analysis of the formation of compounds 13 in different media, with a mobile phase of CH3CN/H2O (25:75, v/v), flow rate of 1.5 mL/min−1, and detection wavelength at 254 nm.
Marinedrugs 17 00294 g005
Figure 6. Alignment of the deduced amino acid sequence of AXH94677.1 in strain 110B with different 2-deoxyfucosyltransferases: A0A1C4KH77 (SCD60843.1) from Streptomyces sp. DvalAA-19, AknK (AAF70102.1) from Streptomyces galilaeus, A0A1M5X8V1 (SHH96196.1) from Streptomyces sp. 3214.6, and A0A2G7A0A5 (PIG12760.1) from Streptomyces sp. 1121.2.
Figure 6. Alignment of the deduced amino acid sequence of AXH94677.1 in strain 110B with different 2-deoxyfucosyltransferases: A0A1C4KH77 (SCD60843.1) from Streptomyces sp. DvalAA-19, AknK (AAF70102.1) from Streptomyces galilaeus, A0A1M5X8V1 (SHH96196.1) from Streptomyces sp. 3214.6, and A0A2G7A0A5 (PIG12760.1) from Streptomyces sp. 1121.2.
Marinedrugs 17 00294 g006
Table 1. 1H and 13C NMR (100 MHz) data of compounds 13 in CD3OD.
Table 1. 1H and 13C NMR (100 MHz) data of compounds 13 in CD3OD.
Position1a2b3b
δcδH (J in Hz)δcδH (J in Hz)δcδH (J in Hz)
2154.98.08 s154.98.12 s155.28.21 s
3125.6 126.2 125.9
4178 178.1 177.9
5128.57.97 d (9.0)128.28.06 d (9.0)128.28.12 d (8.9)
6116.56.84 dd (9.0, 2.4)117.27.09 dd (9.0, 2.3)117.27.15 dd (8.9, 2.2)
7164.7 163.1 163.1
8103.36.76 d (2.4)104.47.18 d (2.3)104.47.25 d (2.2)
9159.8 159.4 159.3
10118.2 119.8 119.7
1′126.7 124.1 125.9
2′, 6′131.37.39 d (8.7)131.47.31 d (9.0)131.37.47 d (8.7)
3′, 5′117.57.05 d (8.7)116.36.78 d (9.0)117.47.13 d (8.7)
4′158.3 158.8 158.3
1″97.65.62 br d (3.5)98.25.78 br d (3.6)97.65.69 br d (3.5)
2″32.12.03 ddd (12.8, 11.9, 3.6)32.92.07 ddd (13.2,12.0, 3.6)33.22.08 ddd (12.8, 12.0, 3.5)
1.90 dd (12.8, 5.0) 1.96 dd (13.2, 5.0) 1.91 dd (12.8, 5.1)
3″66.74.09 ddd (11.9, 5.0, 3.0)66.64.09 ddd (12.0, 5.0, 3.0)66.74.16 ddd (12.0, 5.1, 3.1)
4″72.13.55 br d (3.0)71.93.57 br d (3.0)71.93.62 m
5″68.63.89 q (6.6)69.33.86 q (6.6)69.33.91 m
6″18.41.10 d (6.6)17.21.12 d (6.6)17.21.18 d (6.2)
1‴ 98.25.84 br d (3.5)
2‴ 32.92.12 ddd (13.1, 12.0, 3.5)
1.98 dd (13.1, 5.1)
3‴ 66.54.13 ddd (12.0, 5.1, 3.1)
4‴ 72.13.62 m
5‴ 68.63.95 m
6‴ 17.21.16 d (6.2)
a 1H (600 MHz); b 1H (400 MHz).
Table 2. Cytotoxic activity of compounds 13 against selected human tumor cell lines.
Table 2. Cytotoxic activity of compounds 13 against selected human tumor cell lines.
CompoundsIC50 (μg/mL)
A549HepG2HCT116
117.5552.7116.00
216.9550.9015.40
314.7944.4213.48
Doxorubicin1.020.860.91

Share and Cite

MDPI and ACS Style

Wang, R.-J.; Zhang, S.-Y.; Ye, Y.-H.; Yu, Z.; Qi, H.; Zhang, H.; Xue, Z.-L.; Wang, J.-D.; Wu, M. Three New Isoflavonoid Glycosides from the Mangrove-Derived Actinomycete Micromonospora aurantiaca 110B. Mar. Drugs 2019, 17, 294. https://doi.org/10.3390/md17050294

AMA Style

Wang R-J, Zhang S-Y, Ye Y-H, Yu Z, Qi H, Zhang H, Xue Z-L, Wang J-D, Wu M. Three New Isoflavonoid Glycosides from the Mangrove-Derived Actinomycete Micromonospora aurantiaca 110B. Marine Drugs. 2019; 17(5):294. https://doi.org/10.3390/md17050294

Chicago/Turabian Style

Wang, Rui-Jun, Shao-Yong Zhang, Yang-Hui Ye, Zhen Yu, Huan Qi, Hui Zhang, Zheng-Lian Xue, Ji-Dong Wang, and Min Wu. 2019. "Three New Isoflavonoid Glycosides from the Mangrove-Derived Actinomycete Micromonospora aurantiaca 110B" Marine Drugs 17, no. 5: 294. https://doi.org/10.3390/md17050294

APA Style

Wang, R. -J., Zhang, S. -Y., Ye, Y. -H., Yu, Z., Qi, H., Zhang, H., Xue, Z. -L., Wang, J. -D., & Wu, M. (2019). Three New Isoflavonoid Glycosides from the Mangrove-Derived Actinomycete Micromonospora aurantiaca 110B. Marine Drugs, 17(5), 294. https://doi.org/10.3390/md17050294

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop